Skip to content

Effectiveness of Plum Serum in skin blemishes

A Single blind Clinical study to evaluate the effectiveness and safety of Plum rice water & niacinamide serum for Skin Brightening - NIL

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/12/060475
Enrollment
36
Registered
2023-12-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Plum Rice Water & Niacinamide 10% Serum: Dose: Apply 3 drops serum over the face with finger in outward manner two times a day. For the first 14 days, use 2 drop at the hand treatment s

Sponsors

Pureplay Skin Sciences India Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Gender: Male or Female aged between 18 to 40, with minimum F:M distribution ratio of 2:1 2. Subject willing to give written informed consent 3. Women of child bearing potential must have a negative urine pregnancy test 4. Free of any systemic and dermatologic disorder, which in the opinion of the investigator, will interface with the study results or increase the risk of AE. 5. Are willing to avoid prolonged exposure of the treatment area to ultraviolet radiation (natural orartificial) for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Subjects who are pregnant, breastfeeding, or planning to become pregnant during the study 2. Have any evidence of systematic cancer, squamous cell carcinoma, basal cell carcinoma in the last 5 years, or any other confounding skin condition. 3. Have open sore or open lesions in the treatment area 4. Have any condition that, in the opinion of the investigator would confound the safety and efficacy assessments of the product. 5. Have participated in any interventional clinical trial in the previous 30 days. 6. Have a known sensitivity to any of the constituents of the test product including sensitivities to any of the constituents. 7. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medications (i.e., biologics), blood purifiers and including corticosteroids. 8. Have a history of alcohol or illegal drug/ substance abuse or suspected alcohol or illegal drug/substance abuse in the past 2 years.

Design outcomes

Primary

MeasureTime frame
Change in SGA self-evaluation score blemishes, Smooth skin, open pores, customer satisfaction indexTimepoint: Day 0, Day 14 and Day 28

Secondary

MeasureTime frame
Change in BlemishesTimepoint: Day 0, Day 14 and Day 28;Change in open poresTimepoint: Day 0, Day 14 and Day 28;Change in Skin colorTimepoint: Day 0, Day 14 and Day 28;Change in Skin GlossTimepoint: Day 0, Day 14 and Day 28;change in TEWLTimepoint: 0 min, 30 min;Skin in skin hydrationTimepoint: 0 min, 30 min

Countries

India

Contacts

Public ContactPuneet Mittal

MGCTS(Mittal Global Clinical Trial Services)

puneetmittal@mgcts.org8937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026